MAM
Ignite Mudra bags Sikka Group’s real estate biz
MUMBAI: Sikka Group has appointed Ignite Mudra to handle its real estate company‘s corporate identity revamp and also handle its creative duties.
The agency‘s mandate includes handling the company‘s digital and PR businesses as well.
Sikka Group that also owns companies dealing in automobile, hospitality and advertising, is expected to spend Rs 150-200 million on marketing its real estate businesses.
Ignite Mudra head Sudarshan Banerjee said, “We will be working towards a complete revamp the brand‘s corporate identity. The real estate business in the Delhi-NCR is booming and its highly competitive. There are many players and we are aiming to stand out and make a lot of noise.”
Though the name of the brand will remain the same, the means to communicate the new image will be completely different now.
“To set our client apart from the crowd, we will use all mediums of communications including social networking sites”, Banerjee added.
There was no multi-agency pitch involved but Sikka Group was engaged in discussions with various other agencies.
“The client chose us on the basis of superior strategy diplayed in our presentation”, Banerjee revealed.
Until now, the creative duties were handled by Delhi-based agency Graphic Ads.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
